TrialInvestigational new drugs2004

Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors.

M J A de Jonge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.